(Q35180143)

7 August 2017

Capsid protein: evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys (English)

1 reference

7 August 2017

0 references

9

Thomas Kariuki

1 reference

7 August 2017

Lázaro Gil

1

1 reference

7 August 2017

Alienys Izquierdo

2

1 reference

7 August 2017

Laura Lazo

3

1 reference

7 August 2017

Iris Valdés

4

1 reference

7 August 2017

Peris Ambala

5

1 reference

7 August 2017

Lucy Ochola

6

1 reference

7 August 2017

Ernesto Marcos

7

1 reference

7 August 2017

Edith Suzarte

8

1 reference

7 August 2017

Guadalupe Guzmán

10

1 reference

7 August 2017

Gerardo Guillén

11

1 reference

7 August 2017

Lisset Hermida

12

1 reference

7 August 2017

language of work or name

English

0 references

publication date

29 March 2014

1 reference

7 August 2017

1 reference

7 August 2017

456-457

1 reference

7 August 2017

70-76

1 reference

Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Phylogenetic influences on hormone levels across the primate order

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Nucleotide sequence and deduced amino acid sequence of the nonstructural proteins of dengue type 2 virus, Jamaica genotype: comparative analysis of the full-length genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Full-length cDNA sequence of dengue type 1 virus (Singapore strain S275/90)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Identifying protective dengue vaccines: guide to mastering an empirical process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Stability of interindividual differences in serotonin function and its relationship to severe aggression and competent social behavior in rhesus macaque females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Flavivirus Capsid Is a Dimeric Alpha-Helical Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Global spread and persistence of dengue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Nucleocapsid-like particles of dengue-2 virus enhance the immune response against a recombinant protein of dengue-4 virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

A recombinant capsid protein from Dengue-2 induces protection in mice against homologous virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Evidence that a mechanism for efficient flavivirus budding upregulates MHC class I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Recombinant chimeric virus with wild-type dengue 4 virus premembrane and envelope and virulent yellow fever virus Asibi backbone sequences is dramatically attenuated in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

A structural perspective of the flavivirus life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Catarrhine phylogeny: noncoding DNA evidence for a diphyletic origin of the mangabeys and for a human-chimpanzee clade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Catarrhine primate divergence dates estimated from complete mitochondrial genomes: concordance with fossil and nuclear DNA evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Heterologous prime-boost strategy in non-human primates combining the infective dengue virus and a recombinant protein in a formulation suitable for human use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

A Protective Role for Dengue Virus-Specific CD8+ T Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Role of humoral versus cellular responses induced by a protective dengue vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.03.011

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2014.03.011

1 reference

release_6fusgw433rhjlmgh62zxbkayem

7 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6fusgw433rhjlmgh62zxbkayem

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference